Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (16 quarters reported)
$910M in Q4 2020 → $6.84M now. Hover for any quarter.
As reported for the quarter ended September 30, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| RP Reneo Pharmaceuticals, Inc. | 63.0% | Unchanged | 2,534,220 | $4.31M |
| SB Spruce Bioscience, Inc. | 20.4% | Unchanged | 2,936,281 | $1.39M |
| Xilio Therapeutics, Inc. | 16.6% | Unchanged | 1,441,444 | $1.14M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2024 · filed October 30, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Vapotherm, Inc. | Exited | −52,881 | −$112K | — |
quarter ended June 30, 2024 · filed July 24, 2024
No position changes this quarter.
quarter ended March 31, 2024 · filed May 08, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Allakos, Inc. | Exited | −4,987,522 | −$13.6M | — |
| Vapotherm, Inc. | Added | +329 | +$434 | 0.9% |
quarter ended December 31, 2023 · filed February 12, 2024
No position changes this quarter.
quarter ended September 30, 2023 · filed October 30, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | Exited | −1,621,118 | −$41.9M | — |
| Vapotherm, Inc. | Trimmed | −365,256 | −$924K | 0.3% |
| Allakos, Inc. | Added | +99,590 | +$226K | 28.0% |
quarter ended June 30, 2023 · filed August 07, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| RP Reneo Pharmaceuticals, Inc. | Added | +125,000 | +$820K | 18.4% |
| Vapotherm, Inc. | Trimmed | −5,250 | −$2.36K | 0.2% |
quarter ended March 31, 2023 · filed April 27, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SB Spruce Bioscience, Inc. | Added | +788,000 | +$1.74M | 7.5% |
| Vapotherm, Inc. | Added | +10,500 | +$6.91K | 0.3% |
quarter ended December 31, 2022 · filed February 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | Trimmed | −300,000 | −$5.85M | 36.9% |
Loading...
